Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Clinical trial NCT00988156 · COMPLETED

Trial details

NCT number: NCT00988156
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Partial Epilepsy in Children and Adolescents

Start date: 2007-12-07
Primary completion: 2012-08-20
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.